Rapport Therapeutics (RAPP) Shareholder's Equity (2023 - 2026)

Rapport Therapeutics (RAPP) Shareholder's Equity (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 7.14 Bn
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 595,226.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 14.38 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.71 Bn 91.71 Bn - 502.95 Mn
10 Rapport Therapeutics 1.66 Bn 1.66 Bn - 471.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 471.51 Mn
Dec 31, 2025 484.65 Mn
Sep 30, 2025 511.62 Mn
Jun 30, 2025 263.51 Mn
Mar 31, 2025 285.84 Mn
Dec 31, 2024 305.43 Mn
Sep 30, 2024 323.11 Mn
Jun 30, 2024 336.89 Mn
Mar 31, 2024 -39.63 Mn
Dec 31, 2023 -25.63 Mn
Sep 30, 2023 -13.12 Mn
Jun 30, 2023 -9.43 Mn